Pacific Biosciences Of California (PACB) Amortizatization of Intangibles (2018 - 2026)

Pacific Biosciences Of California (PACB) recorded quarterly Amortizatization of Intangibles of $1.0 million in Q1 2026, up 100.28% quarter-over-quarter from -$364.1 million in Q4 2025, and down 40.21% on a YoY basis from $1.7 million in Q1 2025.

Pacific Biosciences Of California (PACB) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends

Pacific Biosciences Of California's Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 40.21% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at -$361.4 million (down 3122.06% YoY), while the FY2025 annual figure was $4.4 million, down 66.54% from the prior year.
  • Amortizatization of Intangibles was $1.0 million for Q1 2026 at Pacific Biosciences Of California, up from -$364.1 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $5.4 million in Q4 2023 to a low of -$364.1 million in Q4 2025.
  • Historically, Amortizatization of Intangibles has averaged -$19.9 million across 5 years, with a median of $1.3 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles surged 497.93% in 2024, then plunged 15390.38% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $1.3 million in 2022, then soared by 311.42% to $5.4 million in 2023, then tumbled by 55.92% to $2.4 million in 2024, then slumped by 15390.38% to -$364.1 million in 2025, then soared by 100.28% to $1.0 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $1.0 million (Q1 2026), -$364.1 million (Q4 2025), and $833000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 422.00 Mn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 180.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 6.50 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 75.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Pacific Biosciences Of California 402.15 Mn 126.19 Mn 12.84 Mn 1.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.02 Mn
Mar 31, 2026 1.02 Mn
Dec 31, 2025 -364.06 Mn
Dec 31, 2025 -364.06 Mn
Sep 30, 2025 833,000.00
Sep 30, 2025 833,000.00
Jun 30, 2025 833,000.00
Jun 30, 2025 833,000.00
Mar 31, 2025 1.71 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 2.38 Mn
Dec 31, 2024 2.38 Mn
Sep 30, 2024 3.65 Mn
Sep 30, 2024 3.65 Mn
Jun 30, 2024 4.22 Mn
Jun 30, 2024 4.22 Mn
Mar 31, 2024 4.03 Mn
Mar 31, 2024 4.03 Mn
Dec 31, 2023 5.40 Mn
Dec 31, 2023 5.40 Mn